Translating Research Into Practice

The Challenges of Clinical Research in Rare Cancers: Bevacizumab Use in Low-Grade Serous Ovarian and Primary Peritoneal Cancers

Carolyn Grande,(1) CRNP, Constance Visovsky,(2) PhD, RN, ACNP, and Marcia S. Brose,(1) MD, PhD

(1)Department of Otorhinolaryngology, Hospital of the University of Pennsylvania Abramson Cancer Center, Philadelphia, Pennsylvania; (2)University of South Florida College of Nursing, Tampa, Florida

Carolyn Grande, CRNP, Stellar-Chance Laboratories, 422 Curie Blvd, Suite M8D, Philadelphia, PA 19104. E-mail: Carolyn.Grande@uphs.upenn.edu


J Adv Pract Oncol 2017;8:388–391 | https://doi.org/10.6004/jadpro.2017.8.4.7 | © 2017 Harborside Press®


  

ABSTRACT

There are challenges to conducting rare cancer clinical trials due to issues surrounding clinical trial design, patient recruitment, and analysis of the study outcomes. This article highlights the challenges of research and data analysis in rare cancers and proposes future study directions using less traditional approaches.



For access to the full length article, please sign in.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here
click me